MedPath

DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE

These highlights do not include all the information needed to use DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. SEE FULL PRESCRIBING INFORMATION FOR DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use.Initial U.S. Approval: 1998

Approved
Approval ID

17f04726-725f-4839-911d-47fc5e02baae

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 18, 2023

Manufacturers
FDA

Somerset Therapeutics, LLC

DUNS: 079947873

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70069-051
Application NumberANDA207523
Product Classification
M
Marketing Category
C73584
G
Generic Name
DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateDecember 18, 2023
FDA Product Classification

INGREDIENTS (8)

DORZOLAMIDE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: QZO5366EW7
Classification: ACTIM
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95K
Classification: IACT
TIMOLOL MALEATEActive
Quantity: 5 mg in 1 mL
Code: P8Y54F701R
Classification: ACTIM
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)Inactive
Code: S38J6RZN16
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE - FDA Drug Approval Details